Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Fisher & Paykel Healthcare (FPH.NZ)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NZ$)	Price Target (NZ$)	Rating
2021-08-20	33.79	22.65	Sell
2021-11-25	33.78	23.50	Sell
2022-03-23	25.70	21.90	Sell
2022-05-25	19.90	18.40	Sell
2022-08-19	19.85	17.70	Sell
2022-11-30	23.60	20.00	Sell
2023-01-25	25.25	20.90	Sell
2023-05-26	23.98	20.00	Sell
2023-11-10	21.72	23.15	Neutral
2023-11-29	23.80	24.15	Neutral
2024-03-26	26.45	28.50	Neutral
2024-04-10	26.30	29.10	Buy
2024-05-29	28.75	32.80	Buy
2024-08-29	35.20	36.00	Neutral

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.